260 related articles for article (PubMed ID: 30562337)
1. Natamycin versus voriconazole for fungal keratitis.
Retamal J; Ordenes-Cavieres G; Grau-Diez A
Medwave; 2018 Dec; 18(8):e7388. PubMed ID: 30562337
[TBL] [Abstract][Full Text] [Related]
2. Medical interventions for fungal keratitis.
FlorCruz NV; Evans JR
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD004241. PubMed ID: 25855311
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.
Sharma N; Chacko J; Velpandian T; Titiyal JS; Sinha R; Satpathy G; Tandon R; Vajpayee RB
Ophthalmology; 2013 Apr; 120(4):677-81. PubMed ID: 23246119
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Oral Voriconazole Versus Oral Ketoconazole as an Adjunct to Topical Natamycin in Severe Fungal Keratitis: A Randomized Controlled Trial.
Sharma N; Singhal D; Maharana PK; Sinha R; Agarwal T; Upadhyay AD; Velpandian T; Satpathy G; Titiyal JS
Cornea; 2017 Dec; 36(12):1521-1527. PubMed ID: 28902012
[TBL] [Abstract][Full Text] [Related]
5. Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.
Sharma S; Das S; Virdi A; Fernandes M; Sahu SK; Kumar Koday N; Ali MH; Garg P; Motukupally SR
Br J Ophthalmol; 2015 Sep; 99(9):1190-5. PubMed ID: 25740805
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Devi L; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2017 Jun; 135(6):520-525. PubMed ID: 28426856
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
Edwar L; Janna YM; Rozaliyani A; Louisa M
Mycoses; 2020 Oct; 63(10):1128-1132. PubMed ID: 32780874
[TBL] [Abstract][Full Text] [Related]
8. Mycotic Antimicrobial Localized Injection: A Randomized Clinical Trial Evaluating Intrastromal Injection of Voriconazole.
Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Austin A; Pickel J; Porco T; Lietman T; Rose-Nussbaumer J
Ophthalmology; 2019 Aug; 126(8):1084-1089. PubMed ID: 30904540
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Arora R; Gupta D; Goyal J; Kaur R
Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
[TBL] [Abstract][Full Text] [Related]
10. Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
Hoffman JJ; Yadav R; Sanyam SD; Chaudhary P; Roshan A; Singh SK; Singh SK; Mishra SK; Arunga S; Hu VH; Macleod D; Leck A; Burton MJ
Ophthalmology; 2022 May; 129(5):530-541. PubMed ID: 34896126
[TBL] [Abstract][Full Text] [Related]
11. Natamycin and voriconazole in fungal keratitis.
Das M; Murthy SI; Dikshit S; Rathi V
Arch Ophthalmol; 2011 Jun; 129(6):814; author reply 814-5. PubMed ID: 21670358
[No Abstract] [Full Text] [Related]
12. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Prajna L; Srinivasan M; Raghavan A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Porco TC; Acharya NR; Lietman TM;
JAMA Ophthalmol; 2013 Apr; 131(4):422-9. PubMed ID: 23710492
[TBL] [Abstract][Full Text] [Related]
13. Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
Ann Pharmacother; 2009 Jun; 43(6):1139-42. PubMed ID: 19435962
[TBL] [Abstract][Full Text] [Related]
14. Management Algorithm for Fungal Keratitis: The TST (Topical, Systemic, and Targeted Therapy) Protocol.
Sharma N; Sahay P; Maharana PK; Singhal D; Saluja G; Bandivadekar P; Chako J; Agarwal T; Sinha R; Titiyal JS; Satpathy G; Velpandian T
Cornea; 2019 Feb; 38(2):141-145. PubMed ID: 30334872
[TBL] [Abstract][Full Text] [Related]
15. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
Sun CQ; Lalitha P; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Oldenburg CE; Ray KJ; McLeod SD; Acharya NR; Lietman TM;
Ophthalmology; 2014 Aug; 121(8):1495-500.e1. PubMed ID: 24746358
[TBL] [Abstract][Full Text] [Related]
16. [Fungal keratitis caused by Scedosporium apiospermum: first report from Turkey].
Kalkan Akçay E; Açıkgöz ZC; Can ME; Celikbilek N; Dereli Can G; Cağıl N
Mikrobiyol Bul; 2013 Oct; 47(4):727-33. PubMed ID: 24237443
[TBL] [Abstract][Full Text] [Related]
17. Medical interventions for fungal keratitis.
FlorCruz NV; Peczon IV; Evans JR
Cochrane Database Syst Rev; 2012 Feb; (2):CD004241. PubMed ID: 22336802
[TBL] [Abstract][Full Text] [Related]
18. Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.
Prajna VN; Lalitha PS; Mascarenhas J; Krishnan T; Srinivasan M; Vaitilingam CM; Oldenburg CE; Sy A; Keenan JD; Porco TC; Acharya NR; Lietman TM
Br J Ophthalmol; 2012 Nov; 96(11):1440-1. PubMed ID: 22914503
[No Abstract] [Full Text] [Related]
19. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.
Prajna NV; Krishnan T; Rajaraman R; Patel S; Srinivasan M; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Porco TC; Acharya NR; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2016 Dec; 134(12):1365-1372. PubMed ID: 27787540
[TBL] [Abstract][Full Text] [Related]
20. Ramularia Keratitis.
Sluch IM; Maher JH
Cornea; 2022 Feb; 41(2):e1. PubMed ID: 34743103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
